This week’s health news is marked by significant collaborative efforts and legal victories. Antares Therapeutics has secured a $1.9 billion potential deal with Novartis to develop cancer therapies aimed at challenging targets. Meanwhile, Bayer celebrated a major legal win as the U.S. Supreme Court substantially reduced lawsuits related to its Roundup weedkiller.
Ebola continues to pose a formidable threat, with the Africa CDC estimating $1.4 billion in funding needs, tripling initial estimates. Concurrently, the U.S. is bolstering its FDA workforce and tackling influenza outbreaks, marking a crucial time for public health strategy.
In the business health sector, H.B. Fuller has agreed to acquire the UK’s Advanced Medical Solutions Group for $942 million, and Dutch company Prosus has invested $460 million in the French health tech firm Alan, valuing it at $6.3 billion and highlighting the robust activity in health-oriented investments.
(With inputs from agencies.)